Rating History for Trevi Therapeutics (TRVI) by Morgan Stanley

More Stocks Rated by Morgan Stanley | Latest Ratings for TRVI
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/14/2025 Judah Frommer Maintain Overweight
(N/A)		 19.00
(18.00)		  
 		   Details